Antihypertensive effects of the putative T-type calcium channel antagonist mibefradil are mediated by the L-type calcium channel Cav1.2.


Moosmang S, Haider N, Brüderl B, Welling A & Hofmann F

Circ. Res. 2006, 98, 105 – 110